Redox-regulated mechanisms in asthma

Antioxidants and Redox Signaling

Volumn 10, Issue 4, 2008, Pages 769-783

  Hoshino, Tomoaki ^a   Okamoto, Masaki ^a   Takei, Satoko ^a   Sakazaki, Yuki ^a   Iwanaga, Tomoaki ^a   Aizawa, Hisamichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BLEOMYCIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DEXAMETHASONE; GLUTATHIONE; HEME OXYGENASE; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 2; LIPOPOLYSACCHARIDE; MONTELUKAST; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THEOPHYLLINE; THIOREDOXIN 1;

AMINO ACID SEQUENCE; ASTHMA; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISULFIDE BOND; DRUG INHIBITION; HUMAN; INFLAMMATORY CELL; INFLUENZA; LUNG PERFUSION; LYMPHOMA; NONHUMAN; OXIDATIVE STRESS; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SQUAMOUS CELL CARCINOMA; TISSUE INJURY;

ANIMALS; ANTIOXIDANTS; ASTHMA; GLUTATHIONE; HUMANS; MODELS, BIOLOGICAL; OXIDATION-REDUCTION; SUPEROXIDE DISMUTASE; THIOREDOXINS;

EID: 38949207260     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1936     Document Type: Review

References (119)

1. Akira S, Uematsu S, and Takeuchi O. Pathogen recognition and innate immunity. Cell 124: 783-801, 2006.
2. Almolki A, Taille C, Martin GF, Jose PJ, Zedda C, Conti M, Megret J, Henin D, Aubier M, and Boczkowski J. Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol 287: L26-L34, 2004.
3. Arner ES and Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem FEBS 267: 6102-6109, 2000.
4. Assa'ad AH, Ballard ET, Sebastian KD, Loven DP, Boivin GP, and Lierl MB. Effect of superoxide dismutase on a rabbit model of chronic allergic asthma. Ann Allergy Asthma Immunol 80: 215-224, 1998.
5. Barnes PJ. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev 14: 511-522, 2003.
6. Barnes PJ. Endogenous inhibitory mechanisms in asthma. Am J Respir Crit Care Med 161: S176-S181, 2000.
7. Barnes PJ and Woolcock AJ. Difficult asthma. Eur Respir J 12: 1209-1218, 1998.
8. Benayoun L, Druilhe A, Dombret MC, Aubier M, and Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med 167: 1360-1368, 2003.
9. Blyth DI, Wharton TF, Pedrick MS, Savage TJ, and Sanjar S. Airway subepithelial fibrosis in a murine model of atopic asthma: suppression by dexamethasone or anti-interleukin-5 antibody. Am J Respir Cell Mol Biol 23: 241-246, 2000.
10. Bowler RP and Crapo JD. Oxidative stress in airways: is there a role for extracellular superoxide dismutase? Am J Respir Crit Care Med 166: S38-S43, 2002.
11. Busse W, Banks-Schlegel S, Noel P, Ortega H, Taggart V, and Elias J. Future research directions in asthma: an NHLBI Working Group report. Am J Respir Crit Care Med 170: 683-690, 2004.
12. Callister ME, Burke-Gaffney A, Quinlan GJ, Nicholson AG, Florio R, Nakamura H, Yodoi J, and Evans TW. Extracellular thioredoxin levels are increased in patients with acute lung injury. Thorax 61: 521-527, 2006.
13. Carter EP, Garat C, and Imamura M. Continual emerging roles of HO-1: protection against airway inflammation. Am J Physiol Lung Cell Mol Physiol 287: L24-L25, 2004.
14. Christie PE, Jonas M, Tsai CH, Chi EY, and Henderson WR Jr. Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone. Eur Respir J 24: 107-115, 2004.
15. Chung KF and Barnes PJ. Cytokines in asthma. Thorax 54: 825-857, 1999.
16. Comhair SA, Bhathena PR, Dweik RA, Kavuru M, and Erzurum SC. Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet 355: 624, 2000.
17. Das KC, Lewis-Molock Y, and White CW. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol 17: 713-726, 1997.
18. De Raeve HR, Thunnissen FB, Kaneko FT, Guo FH, Lewis M, Kavuru MS, Secic M, Thomassen MJ, and Erzurum SC. Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am J Physiol 272: L148-L154, 1997.
19. Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 103: 11-24, 1999.
20. Ebina M, Takahashi T, Chiba T, and Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma: a 3-D morphometric study. Am Rev Respir Dis 148: 720-726, 1993.
21. Fryer AA, Bianco A, Hepple M, Jones PW, Strange RC, and Spiteri MA. Polymorphism at the glutathione S-transferase GSTP1 locus: a new marker for bronchial hyperresponsiveness and asthma. Am J Respir Crit Care Med 161: 1437-1442, 2000.
22. Fujii S, Nanbu Y, Konishi I, Mori T, Masutani H, and Yodoi J. Immunohistochemical localization of adult T-cell leukaemia-derived factor, a human thioredoxin homologue, in human fetal tissues. Virchows Arch 419: 317-326, 1991.
23. Fujii S, Nanbu Y, Nonogaki H, Konishi I, Mori T, Masutani H, and Yodoi J. Coexpression of adult T-cell leukemia-derived factor, a human thioredoxin homologue, and human papillomavirus DNA in neoplastic cervical squamous epithelium. Cancer 68: 1583-1591, 1991.
24. Fukuse T, Hirata T, Yokomise H, Hasegawa S, Inui K, Mitsui A, Hirakawa T, Hitomi S, Yodoi J, and Wada H. Attenuation of ischaemia reperfusion injury by human thioredoxin. Thorax 50: 387-391, 1995.
25. Gauntt CD, Ohira A, Honda O, Kigasawa K, Fujimoto T, Masutani H, Yodoi J, and Honda Y. Mitochondrial induction of adult T cell leukemia derived factor (ADF/hTx) after oxidative stresses in retinal pigment epithelial cells. Invest Ophthalmol Visual Sci 35: 2916-2923, 1994.
26. Gilliland FD, Gauderman WJ, Vora H, Rappaport E, and Dubeau L. Effects of glutathione-S-transferase M1, T1, and P1 on childhood lung function growth. Am J Respir Crit Care Med 166: 710-716, 2002.
27. Gon Y, Sasada T, Matsui M, Hashimoto S, Takagi Y, Iwata S, Wada H, Horie T, and Yodoi J. Expression of thioredoxin in bleomycin-injured airway epithelium: possible role of protection against bleomycin induced epithelial injury. Life Sci 68: 1877-1888, 2001.
28. Harper R, Wu K, Chang MM, Yoneda K, Pan R, Reddy SP, and Wu R. Activation of nuclear factor-kappa b transcriptional activity in airway epithelial cells by thioredoxin but not by N-acetylcysteine and glutathione. Am J Respir Cell Mol Biol 25: 178-185, 2001.
29. Hashimoto S, Matsumoto K, Gon Y, Furuichi S, Maruoka S, Takeshita I, Hirota K, Yodoi J, and Horie T. Thioredoxin negatively regulates p38 MAP kinase activation and IL-6 production by tumor necrosis factor-alpha. Biochem Biophys Res Commun 258: 443-447, 1999.
30. Hayashi T, Ueno Y, and Okamoto T. Oxidoreductive regulation of nuclear factor kappa B: involvement of a cellular reducing catalyst thioredoxin. J Biol Chem 268: 11380-11388, 1993.
31. Henderson WR Jr, Chiang GK, Tien YT, and Chi EY. Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade. Am J Respir Crit Care Med 173: 718-728, 2006.
32. Hirota K, Matsui M, Iwata S, Nishiyama A, Mori K, and Yodoi J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci U S A 94: 3633-3638, 1997.
33. Holmgren A. Thioredoxin. Annu Rev Biochem 54: 237-271, 1985.
34. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 264: 13963-13966, 1989.
35. Holmgren A and Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 252: 199-208, 1995.
36. Hori K, Katayama M, Sato N, Ishii K, Waga S, and Yodoi J. Neuroprotection by glial cells through adult T cell leukemia-derived factor/human thioredoxin (ADF/TRX). Brain Res 652: 304-310, 1994.
37. Horvath I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, and Barnes PJ. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 53: 668-672, 1998.
38. Hoshino T, Kato S, Oka N, Imaoka H, Kinoshita T, Takei S, Kitasato Y, Kawayama T, Imaizumi T, Yamada K, Young HA, and Aizawa H. Pulmonary inflammation and emphysema: role of the cytokines IL-18 and IL-13. Am J Respir Crit Care Med 176: 49-62, 2007.
39. Hoshino T, Kawase Y, Okamoto M, Yokota K, Yoshino K, Yamamura K, Miyazaki J, Young HA, and Oizumi K. Cutting edge: IL-18-transgenic mice: in vivo evidence of a broad role for IL-18 in modulating immune function. J Immunol 166: 7014-7018, 2001.
40. Hoshino T, Nakamura H, Okamoto M, Kato S, Araya S, Nomiyama K, Oizumi K, Young HA, Aizawa H, and Yodoi J. Redox-active protein thioredoxin prevents proinflammatory cytokine- or bleomycin-induced lung injury. Am J Respir Crit Care Med 168: 1075-1083, 2003.
41. Hoshino T, Wiltrout RH, and Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 162: 5070-5077, 1999.
42. Hoshino T, Yagita H, Ortaldo JR, Wiltrout RH, and Young HA. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4-+ T cells. Eur J Immunol 30: 1998-2006, 2000.
43. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, and Gotoh Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94, 1997.
44. Ichiki H, Hoshino T, Kinoshita T, Imaoka H, Kato S, Inoue H, Nakamura H, Yodoi J, Young HA, and Aizawa H. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma. Biochem Biophys Res Commun 334: 1141-1148, 2005.
45. Imaoka H, Hoshino T, Takei S, Sakazaki Y, Kinoshita T, Okamoto M, Kawayama T, Yodoi J, Kato S, Iwanaga T, and Aizawa H. Effects of thioredoxin on established airway remodeling in a chronic antigen exposure asthma model. Biochem Biophys Res Commun 360: 525-530, 2007.
46. Inman M. Is there a place for anti-remodelling drugs in asthma which may not display immediate clinical efficacy? Eur Respir J 24: 1-2, 2004.
47. Ireland RC, Li SY, and Dougherty JJ. The DNA binding of purified Ah receptor heterodimer is regulated by redox conditions. Arch Biochem Biophys 319: 470-480, 1995.
48. Isowa N, Yoshimura T, Kosaka S, Liu M, Hitomi S, Yodoi J, and Wada H. Human thioredoxin attenuates hypoxia-reoxygenation injury of murine endothelial cells in a thiol-free condition. J Cell Physiol 182: 33-40, 2000.
49. Iwata S, Hori T, Sato N, Ueda-Taniguchi Y, Yamabe T, Nakamura H, Masutani H, and Yodoi J. Thiol-mediated redox regulation of lymphocyte proliferation: possible involvement of adult T cell leukemia-derived factor and glutathione in transferrin receptor expression. J Immunol 152: 5633-5642, 1994.
50. Jamieson DD, Kerr DR, and Unsworth I. Interaction of N-acetylcysteine and bleomycin on hyperbaric oxygen-induced lung damage in mice. Lung 165: 239-247, 1987.
51. Kaimul Ahsan M, Nakamura H, Tanito M, Yamada K, Utsumi H, and Yodoi J. Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced downregulation of Akt. Free Radic Biol Med 39: 1549-1559, 2005.
52. Kinoshita T, Hoshino T, Imaoka H, Ichiki H, Okamoto M, Kawayama T, Yodoi J, Kato S, and Aizawa H. Thioredoxin prevents the development and progression of elastase-induced emphysema. Biochem Biophys Res Commun 354: 712-719, 2007.
53. Kitasato Y, Hoshino T, Okamoto M, Kato S, Koda Y, Nagata N, Kinoshita M, Koga H, Yoon DY, Asao H, Ohmoto H, Koga T, Rikimaru T, and Aizawa H. Enhanced expression of IL-18 and its receptor in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 31: 619-625, 2004.
54. Kobayashi F, Sagawa N, Nanbu Y, Kitaoka Y, Mori T, Fujii S, Nakamura H, Masutani H, and Yodoi J. Biochemical and topological analysis of adult T-cell leukaemia-derived factor, homologous to thioredoxin, in the pregnant human uterus. Hum Reprod (Oxford) 10: 1603-1608, 1995.
55. Koike E, Hirano S, Shimojo N, and Kobayashi T. cDNA microarray analysis of gene expression in rat alveolar macrophages in response to organic extract of diesel exhaust particles. Toxicol Sci 67: 241-246, 2002.
56. Koike Y, Hisada T, Utsugi M, Ishizuka T, Shimizu Y, Ono A, Murata Y, Hamuro J, Mori M, and Dobashi K. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am J Respir Cell Mol Biol, 2007 (Epub ahead).
57. Krishna MT, Madden J, Teran LM, Biscione GL, Lau LC, Withers NJ, Sandstrom T, Mudway I, Kelly FJ, Walls A, Frew AJ, and Holgate ST. Effects of 0.2 ppm ozone on biomarkers of inflammation in bronchoalveolar lavage fluid and bronchial mucosa of healthy subjects. Eur Respir J 11: 1294-1300, 1998.
58. MacNee W. Oxidants/antioxidants and COPD. Chest 117: 303S-317S, 2000.
59. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 429: 195-207, 2001.
60. Maestrelli P, El Messlemani AH, De Fina O, Nowicki Y, Saetta M, Mapp C, and Fabbri LM. Increased expression of heme oxygenase (HO)-1 in alveolar spaces and HO-2 in alveolar walls of smokers. Am J Respir Crit Care Med 164: 1508-1513, 2001.
61. Makino Y, Yoshikawa N, Okamoto K, Hirota K, Yodoi J, Makino I, and Tanaka H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J Biol Chem 274: 3182-3188, 1999.
62. Masutani H, Bai J, Kim YC, and Yodoi J. Thioredoxin as a neurotrophic cofactor and an important regulator of neuroprotection. Mol Neurobiol 29: 229-242, 2004.
63. Matsuda M, Masutani H, Nakamura H, Miyajima S, Yamauchi A, Yonehara S, Uchida A, Irimajiri K, Horiuchi A, and Yodoi J. Protective activity of adult T cell leukemia-derived factor (ADF) against tumor necrosis factor-dependent cytotoxicity on U937 cells. J Immunol 147: 3837-3841, 1991.
64. Matsui M, Oshima M, Oshima H, Takaku K, Maruyama T, Yodoi J, and Taketo MM. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev Biol 178: 179-185, 1996.
65. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, Koyasu S, Matsumoto K, Takeda K, and Ichijo H. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat Immunol 6: 587-592, 2005.
66. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, and Hay RT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20: 3821-3830, 1992.
67. 2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12: 2005-2015, 1993.
68. Mitsui A, Hamuro J, Nakamura H, Kondo N, Hirabayashi Y, Ishizaki-Koizumi S, Hirakawa T, Inoue T, and Yodoi J. Overexpression of human thioredoxin in transgenic mice controls oxidative stress and life span. Antioxid Redox Signal 4: 693-696, 2002.
69. Mochida Y, Takeda K, Saitoh M, Nishitoh H, Amagasa T, Ninomiya-Tsuji J, Matsumoto K, and Ichijo H. ASK1 inhibits interleukin-1-induced NF-kappa B activity through disruption of TRAF6-TAK1 interaction. J Biol Chem 275: 32747-32752, 2000.
70. Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, Redondo JM, and de Landazuri MO. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood 88: 3482-3490, 1996.
71. Nakamura H, De Rosa SC, Yodoi J, Holmgren A, Ghezzi P, and Herzenberg LA. Chronic elevation of plasma thioredoxin: inhibition of chemotaxis and curtailment of life expectancy in AIDS. Proc Natl Acad Sci U S A 98: 2688-2693, 2001.
72. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, and Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci U S A 98: 15143-15148, 2001.
73. Nakamura H, Masutani H, Tagaya Y, Yamauchi A, Inamoto T, Nanbu Y, Fujii S, Ozawa K, and Yodoi J. Expression and growth-promoting effect of adult T-cell leukemia-derived factor: a human thioredoxin homologue in hepatocellular carcinoma. Cancer 69: 2091-2097, 1992.
74. Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, Inamoto T, Yamaoka Y, Ozawa K, and Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 42: 75-80, 1994.
75. Nakamura H, Nakamura K, and Yodoi J. Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997.
76. Nakamura H, Tamura S, Watanabe I, Iwasaki T, and Yodoi J. Enhanced resistancy of thioredoxin-transgenic mice against influenza virus-induced pneumonia. Immunol Lett 82: 165-170, 2002.
77. Nakamura T, Nakamura H, Hoshino T, Ueda S, Wada H, and Yodoi J. Redox regulation of lung inflammation by thioredoxin. Antioxid Redox Signal 7: 60-71, 2005.
78. Nakanishi K, Yoshimoto T, Tsutsui H, and Okamura H. Interleukin-18 regulates both th1 and th2 responses. Annu Rev Immunol 19: 423-474, 2001.
79. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, and Iwamoto I. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 104: 5-11, 1999.
80. Nishinaka Y, Nishiyama A, Masutani H, Oka S, Ahsan KM, Nakayama Y, Ishii Y, Nakamura H, Maeda M, and Yodoi J. Loss of thioredoxin-binding protein-2/vitamin D3 up-regulated protein 1 in human T-cell leukemia virus type I-dependent T-cell transformation: implications for adult T-cell leukemia leukemogenesis. Cancer Res 64: 1287-1292, 2004.
81. Nishitoh H, Matsuzawa A, Tobiume K, Saegusa K, Takeda K, Inoue K, Hori S, Kakizuka A, and Ichijo H. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16: 1345-1355, 2002.
82. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, and Yodoi J. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274: 21645-21650, 1999.
83. Nishiyama A, Ohno T, Iwata S, Matsui M, Hirota K, Masutani H, Nakamura H, and Yodoi J. Demonstration of the interaction of thioredoxin with p40phox, a phagocyte oxidase component, using a yeast two-hybrid system. Immunol Lett 68: 155-159, 1999.
84. Oda T, Akaike T, Hamamoto T, Suzuki F, Hirano T, and Maeda H. Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244: 974-976, 1989.
85. Oka S, Liu W, Masutani H, Hirata H, Shinkai Y, Yamada S, Yoshida T, Nakamura H, and Yodoi J. Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome. FASEB J 20: 121-123, 2006.
86. Okamoto M, Kato S, Oizumi K, Kinoshita M, Inoue Y, Hoshino K, Akira S, McKenzie AN, Young HA, and Hoshino T. Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia. Blood 99: 1289-1298, 2002.
87. Ooie T, Takahashi N, Saikawa T, Nawata T, Arikawa M, Yamanaka K, Hara M, Shimada T, and Sakata T. Single oral dose of geranylgeranylacetone induces heat-shock protein 72 and renders protection against ischemia/reperfusion injury in rat heart. Circulation 104: 1837-1843, 2001.
88. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, and Choi AM. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 103: 1047-1054, 1999.
89. Pauwels RA and Rabe KF. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364: 613-620, 2004.
90. Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, and Jeffery PK. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 167: 78-82, 2003.
91. Piguet PF, Collart MA, Grau GE, Kapanci Y, and Vassalli P. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J Exp Med 170: 655-663, 1989.
92. Prieto-Alamo MJ, Jurado J, Gallardo-Madueno R, Monje-Casas F, Holmgren A, and Pueyo C. Transcriptional regulation of glutaredoxin and thioredoxin pathways and related enzymes in response to oxidative stress. J Biol Chem 275: 13398-13405, 2000.
93. Rahman I and MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 16: 534-554, 2000.
94. Rahman I, Morrison D, Donaldson K, and MacNee W. Systemic oxidative stress in asthma, COPD, and smokers. Am J Respir Crit Care Med 154: 1055-1060, 1996.
95. Rennard SI. Repair mechanisms in asthma. J Allergy Clin Immunol 98: S278-S286, 1996.
96. Repine JE, Bast A, and Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease: Oxidative Stress Study Group. Am J Respir Crit Care Med 156: 341-357, 1997.
97. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. Nat Immunol 3: 1129-1134, 2002.
98. Rhee SG, Kim KH, Chae HZ, Yim MB, Uchida K, Netto LE, and Stadtman ER. Antioxidant defense mechanisms: a new thiol-specific antioxidant enzyme. Ann N Y Acad Sci 738: 86-92, 1994.
99. Sachi Y, Hirota K, Masutani H, Toda K, Okamoto T, Takigawa M, and Yodoi J. Induction of ADF/TRX by oxidative stress in keratinocytes and lymphoid cells. Immunol Lett 44: 189-193, 1995.
100. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, and Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 17: 2596-2606, 1998.
101. Sasada T, Iwata S, Sato N, Kitaoka Y, Hirota K, Nakamura K, Nishiyama A, Taniguchi Y, Takabayashi A, and Yodoi J. Redox control of resistance to cis-diamminedichloroplatinum (II) (CDDP): protective effect of human thioredoxin against CDDP-induced cytotoxicity. J Clin Invest 97: 2268-2276, 1996.
102. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, and Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 235: 1043-1046, 1987.
103. Tagaya Y, Maeda Y, Mitsui A, Kondo N, Matsui H, Hamuro J, Brown N, Arai K, Yokota T, Wakasugi H, and Yodoi J. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin: possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 8: 757-764, 1989.
104. Takagi Y, Mitsui A, Nishiyama A, Nozaki K, Sono H, Gon Y, Hashimoto N, and Yodoi J. Overexpression of thioredoxin in transgenic mice attenuates focal ischemic brain damage. Proc Natl Acad Sci U S A 96: 4131-4136, 1999.
105. Taniguchi Y, Taniguchi-Ueda Y, Mori K, and Yodoi J. A novel promoter sequence is involved in the oxidative stress-induced expression of the adult T-cell leukemia-derived factor (ADF)/human thioredoxin (Trx) gene. Nucleic Acids Res 24: 2746-2752, 1996.
106. Tanito M, Masutani H, Kim YC, Nishikawa M, Ohira A, and Yodoi J. Sulforaphane induces thioredoxin through the antioxidant-responsive element and attenuates retinal light damage in mice. Invest Ophthalmol Visual Sci 46: 979-987, 2005.
107. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, and Ichijo H. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2: 222-228, 2001.
108. Tomimoto H, Akiguchi I, Wakita H, Kimura J, Hori K, and Yodoi J. Astroglial expression of ATL-derived factor, a human thioredoxin homologue, in the gerbil brain after transient global ischemia. Brain Res 625: 1-8, 1993.
109. Ueda S, Nakamura T, Yamada A, Teratani A, Matsui N, Furukawa S, Hoshino Y, Narita M, Yodoi J, and Nakamura H. Recombinant human thioredoxin suppresses lipopolysaccharide-induced bronchoalveolar neutrophil infiltration in rat. Life Sci 79: 1170-1177, 2006.
110. Uematsu S and Akira S. Toll-like receptors and type I interferons. J Biol Chem 282: 15319-15323, 2007.
111. Ueno M, Masutani H, Arai RJ, Yamauchi A, Hirota K, Sakai T, Inamoto T, Yamaoka Y, Yodoi J, and Nikaido T. Thioredoxin-dependent redox regulation of p53-mediated p21 activation. J Biol Chem 274: 35809-35815, 1999.
112. Vanacker NJ, Palmans E, Kips JC, and Pauwels RA. Fluticasone inhibits but does not reverse allergen-induced structural airway changes. Am J Respir Crit Care Med 163: 674-679, 2001.
113. Wada H, Hirata T, Decampos KN, Hitomi S, and Slutsky AS. Effect of the combination of human thioredoxin and L-cysteine on ischemia-reperfusion injury in isolated rat lungs. Eur Surg Res Eur Chir Forschung 27: 363-370, 1995.
114. Wang CG, Du T, Xu LJ, and Martin JG. Role of leukotriene D4 in allergen-induced increases in airway smooth muscle in the rat. Am Rev Respir Dis 148: 413-417, 1993.
115. Wu X, Bishopric NH, Discher DJ, Murphy BJ, and Webster KA. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol 16: 1035-1046, 1996.
116. Yagi K, Wada H, Fukuse T, Hirata T, Liu CJ, Bando T, Kosaka S, Okubo K, Gro T, Yokomise H, and et al. Inhibition of reperfusion injury by rADF/human thioredoxin in canine lung transplantation. Transplant Proc 26: 878-879, 1994.
117. Yamada T, Iwasaki Y, Nagata K, Fushiki S, Nakamura H, Marunaka Y, and Yodoi J. Thioredoxin-1 protects against hyperoxia-induced apoptosis in cells of the alveolar walls. Pulm Pharmacol Ther 2006.
118. Yamada Y, Nakamura H, Adachi T, Sannohe S, Oyamada H, Kayaba H, Yodoi J, and Chihara J. Elevated serum levels of thioredoxin in patients with acute exacerbation of asthma. Immunol Lett 86: 199-205, 2003.
119. Zanconato S, Scollo M, Zaramella C, Landi L, Zacchello F, and Baraldi E. Exhaled carbon monoxide levels after a course of oral prednisone in children with asthma exacerbation. J Allergy Clin Immunol 109: 440-445, 2002.